Download PDF
Thromb Haemost 2009; 102(06): 1110-1116
DOI: 10.1160/TH09-04-0250
Theme Issue Article
Schattauer GmbH

Antimicrobial and immunoregulatory effector mechanisms in human endothelial cells

Indoleamine 2,3-dioxygenase versus inducible nitric oxide synthase
Walter Däubener
1   Institute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
,
Silvia K. Schmidt
1   Institute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
,
Kathrin Heseler
1   Institute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
,
Katrin H. Spekker
1   Institute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
,
Colin R. MacKenzie
1   Institute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
› Author AffiliationsFinancial support: This work was supported by the “Deutsche Forschungsgemeinschaft” and the “Ministerium für Bildung und Forschung” to W.D.
Further Information

Publication History

Received: 10 June 2009

Accepted after minor revision: 28 June 2009

Publication Date:
28 November 2017 (online)

    Permissions and Reprints

Summary

In infectious diseases, interferon-gamma (IFN-γ) is generally accepted as one of the most important inducers of antimicrobial and immunoregulatory effects, and both seemingly contradictory effects, can be mediated by the same effector molecules. In detail, several IFN-γ induced enzymes such as the inducible nitric oxide synthase (iNOS) as well as the indoleamine 2,3-dioxygenase (IDO) also exert this double function. In this review we focus on antimicrobial and immunoregulatory properties of both enzymes expressed by human endothelial cells, which are prominent players in infectious diseases, tumour immunology and transplant medicine.

Keywords

Endothelial cells - inducible nitric oxide synthase - indoleamine 2,3-dioxygenase - interferon-gamma - effector mechanisms
 

  • References

  • 1 Griffioen AW, Vyth-Dreese FA. Angiostasis as a way to improve immunotherapy. Thromb Haemost 2009; 101: 1025-1031.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Dehio C. Bartonella-host-cell interactions and vascular tumour formation. Nat Rev Microbiol 2005; 03: 621-631.
    CrossrefPubMedGoogle Scholar
  • 3 Walker DH. Rickettsiae and rickettsial infections: the current state of knowledge. Clin Infect Dis 2007; 45 (Suppl. 01) S39-S44.
    CrossrefPubMedGoogle Scholar
  • 4 Beekhuizen H, van de Gevel JS. Gamma interferon confers resistance to infection with Staphylococcus aureus in human vascular endothelial cells by cooperative proinflammatory and enhanced intrinsic antibacterial activities. Infect Immun 2007; 75: 5615-5626.
    CrossrefPubMedGoogle Scholar
  • 5 De Assis MC, Da Costa AO, Barja-Fidalgo TC. et al. Human endothelial cells are activated by interferongamma plus tumour necrosis factor-alpha to kill intracellular Pseudomonas aeruginosa . Immunology 2000; 101: 271-278.
    CrossrefPubMedGoogle Scholar
  • 6 Hunt NH, Golenser J, Chan-Ling T. et al. Immunopathogenesis of cerebral malaria. Int J Parasitol 2006; 36: 569-582.
    CrossrefPubMedGoogle Scholar
  • 7 Grubb SE, Murdoch C, Sudbery PE. et al. Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis. Infect Immun 2008; 76: 4370-4377.
    CrossrefPubMedGoogle Scholar
  • 8 Müthing J, Schweppe CH, Karch H. et al. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb Haemost 2009; 101: 252-264.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Jong A, Wu CH, Zhou W. et al. Infectomic analysis of gene expression profiles of human brain microvascular endothelial cells infected with Cryptococcus neoformans . J Biomed Biotechnol 2008; 2008: 375620.
    PubMedGoogle Scholar
  • 10 Bolovan-Fritts CA, Trout RN, Spector SA. Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells. J Virol 2004; 78: 13173-13181.
    CrossrefPubMedGoogle Scholar
  • 11 Däubener W, Spors B, Hucke C. et al. Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase. Infect Immun 2001; 69: 6527-6531.
    CrossrefPubMedGoogle Scholar
  • 12 Schroten H, Spors B, Hucke C. et al. Potential role of human brain microvascular endothelial cells in the pathogenesis of brain abscess: inhibition of Staphylococcus aureus by activation of indoleamine 2,3-dioxygenase. Neuropediatrics 2001; 32: 206-210.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Woods ME, Olano JP. Host defenses to Rickettsia rickettsii infection contribute to increased microvascular permeability in human cerebral endothelial cells. J Clin Immunol 2008; 28: 174-185.
    CrossrefPubMedGoogle Scholar
  • 14 Adam R, Rüssing D, Adams O. et al. Role of human brain microvascular endothelial cells during central nervous system infection. Significance of indoleamine 2,3-dioxygenase in antimicrobial defence and immunoregulation. Thromb Haemost 2005; 94: 341-346.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 MacKenzie CR, Heseler K, Müller A. et al. Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. Curr Drug Metab 2007; 08: 237-244.
    CrossrefPubMedGoogle Scholar
  • 16 Chi JT, Chang HY, Haraldsen G. et al. Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A 2003; 100: 10623-10628.
    CrossrefPubMedGoogle Scholar
  • 17 Bogdan C, Rollinghoff M, Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 2000; 12: 64-76.
    CrossrefPubMedGoogle Scholar
  • 18 Kroll J, Waltenberger J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 1998; 252: 743-746.
    CrossrefPubMedGoogle Scholar
  • 19 Assis MC, Freitas C, Saliba AM. et al. Up-regulation of Fas expression by Pseudomonas aeruginosainfected endothelial cells depends on modulation of iNOS and enhanced production of NO induced by bacterial type III secreted proteins. Int J Mol Med 2006; 18: 355-363.
    PubMedGoogle Scholar
  • 20 Pino P, Vouldoukis I, Kolb JP. et al. Plasmodium falciparum-infected erythrocyte adhesion induces caspase activation and apoptosis in human endothelial cells. J Infect Dis 2003; 187: 1283-1290.
    CrossrefPubMedGoogle Scholar
  • 21 Gomez RM, Pozner RG, Lazzari MA. et al. Endothelial cell function alteration after Junin virus infection. Thromb Haemost 2003; 90: 326-333.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Matejovic M, Krouzecky A, Radej J. Coagulation and endothelial dysfunction during long-term hyperdynamic porcine bacteremia-effects of selective inducible nitric oxide synthase inhibition. Thromb Haemost 2007; 97: 304-309.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Rosenkranz-Weiss P, Sessa WC, Milstien S. et al. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest 1994; 93: 2236-2243.
    CrossrefPubMedGoogle Scholar
  • 24 Feng HM, Walker DH. Mechanisms of intracellular killing of Rickettsia conorii in infected human endothelial cells, hepatocytes, and macrophages. Infect Immun 2000; 68: 6729-6736.
    CrossrefPubMedGoogle Scholar
  • 25 Orpana A, Ranta V, Mikkola T. et al. Inducible nitric oxide and prostacyclin productions are differently controlled by extracellular matrix and cell density in human vascular endothelial cells. J Cell Biochem 1997; 64: 538-546.
    CrossrefPubMedGoogle Scholar
  • 26 Däubener W, Nockemann S, Gutsche M. et al. Heparin inhibits the antiparasitic and immune modulatory effects of human recombinant interferon-gamma. Eur J Immunol 1995; 25: 688-692.
    CrossrefPubMedGoogle Scholar
  • 27 Däubener W, Gutsche M, Nockemann S. et al. Protamine enhances the activity of human recombinant interferon-gamma. J Interferon Cytokine Res 1996; 16: 531-536.
    CrossrefPubMedGoogle Scholar
  • 28 Pfefferkorn ER. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci U S A 1984; 81: 908-912.
    CrossrefPubMedGoogle Scholar
  • 29 Munn DH, Zhou M, Attwood JT. et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281: 1191-1193.
    CrossrefPubMedGoogle Scholar
  • 30 Maghzal GJ, Thomas SR, Hunt NH. et al. Cytochrome b5, not superoxide anion radical, is a major reductant of indoleamine 2,3-dioxygenase in human cells. J Biol Chem 2008; 283: 12014-12025.
    CrossrefPubMedGoogle Scholar
  • 31 Shashar N, Harosi FI, Banaszak AT. et al. UV radiation blocking compounds in the eye of the cuttlefish Sepia officinalis . Biol Bull 1998; 195: 187-188.
    CrossrefPubMedGoogle Scholar
  • 32 Takikawa O, Littlejohn TK, Truscott RJ. Indoleamine 2,3-dioxygenase in the human lens, the first enzyme in the synthesis of UV filters. Exp Eye Res 2001; 72: 271-277.
    CrossrefPubMedGoogle Scholar
  • 33 Serbecic N, Beutelspacher SC. Indoleamine 2,3-dioxygenase protects corneal endothelial cells from UV mediated damage. Exp Eye Res 2006; 82: 416-426.
    CrossrefPubMedGoogle Scholar
  • 34 Adam RA, Tenenbaum T, Valentin-Weigand P. et al. Porcine choroid plexus epithelial cells induce Streptococcus suis bacteriostasis in vitro . Infect Immun 2004; 72: 3084-3087.
    CrossrefPubMedGoogle Scholar
  • 35 MacKenzie CR, Hadding U, Däubener W. Interferon-gamma-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci. J Infect Dis 1998; 178: 875-878.
    CrossrefPubMedGoogle Scholar
  • 36 MacKenzie CR, Hucke C, Müller D. et al. Growth inhibition of multiresistant enterococci by interferongamma-activated human uro-epithelial cells. J Med Microbiol 1999; 48: 935-941.
    CrossrefPubMedGoogle Scholar
  • 37 Byrne GI, Lehmann LK, Landry GJ. Induction of tryptophan catabolism is the mechanism for gammainterferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun 1986; 53: 347-351.
    PubMedGoogle Scholar
  • 38 Beutelspacher SC, Tan PH, McClure MO. et al. Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am J Transplant 2006; 06: 1320-1330.
    CrossrefPubMedGoogle Scholar
  • 39 Müller A, Heseler K, Schmidt SK. et al. The missing link between Indoleamine 2,3-dioxygenase mediated antimicrobial and immunoregulatory effects. J Cell Mol Med 2009; 06: 1125-1135.
    PubMedGoogle Scholar
  • 40 Hansen AM, Ball HJ, Mitchell AJ. et al. Increased expression of indoleamine 2,3-dioxygenase in murine malaria infection is predominantly localised to the vascular endothelium. Int J Parasitol 2004; 34: 1309-1319.
    CrossrefPubMedGoogle Scholar
  • 41 Woodman JP, Dimier IH, Bout DT. Human endothelial cells are activated by IFN-gamma to inhibit Toxoplasma gondii replication. Inhibition is due to a different mechanism from that existing in mouse macrophages and human fibroblasts. J Immunol 1991; 147: 2019-2023.
    PubMedGoogle Scholar
  • 42 Terajima M, Leporati AM. Role of indoleamine 2,3-dioxygenase in antiviral activity of interferongamma against vaccinia virus. Viral Immunol 2005; 18: 722-729.
    CrossrefPubMedGoogle Scholar
  • 43 Obojes K, Andres O, Kim KS. et al. Indoleamine 2,3-dioxygenase mediates cell type-specific antimeasles virus activity of gamma interferon. J Virol 2005; 79: 7768-7776.
    CrossrefPubMedGoogle Scholar
  • 44 Bodaghi B, Goureau O, Zipeto D. et al. Role of IFN-gamma-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J Immunol 1999; 162: 957-964.
    PubMedGoogle Scholar
  • 45 Adams O, Besken K, Oberdörfer C. et al. Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. J Virol 2004; 78: 2632-2636.
    CrossrefPubMedGoogle Scholar
  • 46 Adams O, Besken K, Oberdörfer C. et al. Inhibition of human herpes simplex virus type 2 by interferon gamma and tumor necrosis factor alpha is mediated by indoleamine 2,3-dioxygenase. Microbes Infect 2004; 06: 806-812.
    CrossrefPubMedGoogle Scholar
  • 47 Miller DM, Rahill BM, Boss JM. et al. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 1998; 187: 675-683.
    CrossrefPubMedGoogle Scholar
  • 48 Honig A, Rieger L, Kapp M. et al. Indoleamine 2,3-dioxygenase (IDO) expression in invasive extravillous trophoblast supports role of the enzyme for materno-fetal tolerance. J Reprod Immunol 2004; 61: 79-86.
    CrossrefPubMedGoogle Scholar
  • 49 Ligam P, Manuelpillai U, Wallace EM. et al. Localisation of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in the human placenta and decidua: implications for role of the kynurenine pathway in pregnancy. Placenta 2005; 26: 498-404.
    CrossrefPubMedGoogle Scholar
  • 50 Drenzek JG, Breburda EE, Burleigh DW. et al. Expression of indoleamine 2,3-dioxygenase in the rhesus monkey and common marmoset. J Reprod Immunol 2008; 78: 125-133.
    CrossrefPubMedGoogle Scholar
  • 51 Kwidzinski E, Bunse J, Aktas O. et al. Indolamine 2,3-dioxygenase is expressed in the CNS and downregulates autoimmune inflammation. FASEB J 2005; 19: 1347-1349.
    CrossrefPubMedGoogle Scholar
  • 52 Sakurai K, Zou JP, Tschetter Ward JR. et al. Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 2002; 129: 186-196.
    CrossrefPubMedGoogle Scholar
  • 53 Grohmann U, Fallarino F, Bianchi R. et al. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J Exp Med 2003; 198: 153-160.
    CrossrefPubMedGoogle Scholar
  • 54 Ozaki Y, Edelstein MP, Duch DS. Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma. Proc Natl Acad Sci U S A 1988; 85: 1242-1246.
    CrossrefPubMedGoogle Scholar
  • 55 Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 2007; 117: 1147-1154.
    CrossrefPubMedGoogle Scholar
  • 56 Uyttenhove C, Pilotte L, Theate I. et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 2003; 09: 1269-1274.
    CrossrefPubMedGoogle Scholar
  • 57 Munn DH, Sharma MD, Hou D. et al. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 2004; 114: 280-290.
    CrossrefPubMedGoogle Scholar
  • 58 Feder-Mengus C, Wyler S, Hudolin T. et al. High expression of indoleamine 2,3-dioxygenase gene in prostate cancer. Eur J Cancer 2008; 44: 2266-2275.
    CrossrefPubMedGoogle Scholar
  • 59 Riesenberg R, Weiler C, Spring O. et al. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma. Clin Cancer Res 2007; 13: 6993-6902.
    CrossrefPubMedGoogle Scholar
  • 60 Ma W, Pober JS. Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4+ T cells. J Immunol 1998; 161: 2158-2167.
    PubMedGoogle Scholar
  • 61 McDouall RM, Page CS, Hafizi S. et al. Alloproliferation of purified CD4+ T cells to adult human heart endothelial cells, and study of second-signal requirements. Immunology 1996; 89: 220-226.
    CrossrefPubMedGoogle Scholar
  • 62 Beutelspacher SC, Pillai R, Watson MP. et al. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol 2006; 36: 690-700.
    CrossrefPubMedGoogle Scholar
  • 63 Liu H, Liu L, Fletcher BS. et al. Novel action of indoleamine 2,3-dioxygenase attenuating acute lung allograft injury. Am J Respir Crit Care Med 2006; 173: 566-572.
    CrossrefPubMedGoogle Scholar
  • 64 Liu H, Liu L, Visner GA. Nonviral gene delivery with indoleamine 2,3-dioxygenase targeting pulmonary endothelium protects against ischemia-reperfusion injury. Am J Transplant 2007; 07: 2291-2300.
    CrossrefPubMedGoogle Scholar